Mammary secretory carcinoma (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mammary secretory carcinoma" in English language version.

refsWebsite

Global rank English rank

37nih.gov

4^th place

23doi.org

2^nd place

9semanticscholar.org

11^th place

8^th place

1harvard.edu

18^th place

17^th place

doi.org

Gong P, Xia C, Yang Y, Lei W, Yang W, Yu J, Ji Y, Ren L, Ye F (July 2021). "Clinicopathologic profiling and oncologic outcomes of secretory carcinoma of the breast". Scientific Reports. 11 (1): 14738. Bibcode:2021NatSR..1114738G. doi:10.1038/s41598-021-94351-w. PMC 8289843. PMID 34282256.
Carretero-Barrio I, Santón A, Caniego Casas T, López Miranda E, Reguero-Callejas ME, Pérez-Mies B, Benito A, Palacios J (February 2022). "Cytological and molecular characterization of secretory breast carcinoma". Diagnostic Cytopathology. 50 (7): E174–E180. doi:10.1002/dc.24945. PMC 9303577. PMID 35156343. S2CID 246813006.
McDivitt RW, Stewart FW (January 1966). "Breast carcinoma in children". JAMA. 195 (5): 388–90. doi:10.1001/jama.1966.03100050096033. PMID 4285563.
Novochadlo Klüppel E, Rodrigues da Costa L, Marquetto Tognolo C, do Nascimento A, Grignet Ribeiro M, Girardi Fachin C (2020). "Secretory breast carcinoma in a male child: Case report and literature review". International Journal of Surgery Case Reports. 73: 310–314. doi:10.1016/j.ijscr.2020.07.040. PMC 7394736. PMID 32736235.
Knaus ME, Grabowksi JE (August 2021). "Pediatric Breast Masses: An Overview of the Subtypes, Workup, Imaging, and Management". Advances in Pediatrics. 68: 195–209. doi:10.1016/j.yapd.2021.05.006. PMID 34243852. S2CID 235786044.
Loo SK, Yates ME, Yang S, Oesterreich S, Lee AV, Wang XS (May 2022). "Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance". Genes, Chromosomes & Cancer. 61 (5): 261–273. doi:10.1002/gcc.23029. PMC 8930468. PMID 35106856.
Tavassoli FA, Norris HJ (May 1980). "Secretory carcinoma of the breast". Cancer. 45 (9): 2404–13. doi:10.1002/1097-0142(19800501)45:9<2404::aid-cncr2820450928>3.0.co;2-8. PMID 6445777. S2CID 9074530.
Hoda RS, Brogi E, Pareja F, Nanjangud G, Murray MP, Weigelt B, Reis-Filho JS, Wen HY (August 2019). "Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential". Histopathology. 75 (2): 213–224. doi:10.1111/his.13879. PMC 6646069. PMID 31012486.
Vasanthi V, Ramadoss R (2021). "Secretory carcinoma of salivary gland - A systematic review of pediatric case reports and case series". Journal of Oral and Maxillofacial Pathology. 25 (2): 327–331. doi:10.4103/0973-029X.325236. PMC 8491356. PMID 34703129.
Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simões M, Tallini G, Mete O (March 2022). "Overview of the 2022 WHO Classification of Thyroid Neoplasms". Endocrine Pathology. 33 (1): 27–63. doi:10.1007/s12022-022-09707-3. PMID 35288841. S2CID 247440666.
Amin SM, Beattie A, Ling X, Jennings LJ, Guitart J (November 2016). "Primary Cutaneous Mammary Analog Secretory Carcinoma With ETV6-NTRK3 Translocation". The American Journal of Dermatopathology. 38 (11): 842–845. doi:10.1097/DAD.0000000000000590. PMID 27763904. S2CID 46372654.
Taniguchi K, Yanai H, Kaji T, Kubo T, Ennishi D, Hirasawa A, Yoshino T (August 2021). "Secretory carcinoma of the skin with lymph node metastases and recurrence in both lungs: A case report". Journal of Cutaneous Pathology. 48 (8): 1069–1074. doi:10.1111/cup.14028. PMID 33882152. S2CID 233352244.
Tang H, Zhong L, Jiang H, Zhang Y, Liang G, Chen G, Xie G (June 2021). "Secretory carcinoma of the breast with multiple distant metastases in the brain and unfavorable prognosis: a case report and literature review". Diagnostic Pathology. 16 (1): 56. doi:10.1186/s13000-021-01115-1. PMC 8223364. PMID 34162406.
Banerjee N, Banerjee D, Choudhary N (2021). "Secretory carcinoma of the breast, commonly exhibits the features of low grade, triple negative breast carcinoma- A Case report with updated review of literature". Autopsy & Case Reports. 11: e2020227. doi:10.4322/acr.2020.227. PMC 8101654. PMID 34277491.
Li L, Wu N, Li F, Li L, Wei L, Liu J (February 2019). "Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma". Cancer Biology & Medicine. 16 (1): 139–146. doi:10.20892/j.issn.2095-3941.2018.0035. PMC 6528460. PMID 31119054.
Yang Y, Wang Z, Pan G, Li S, Wu Y, Liu L (August 2019). "Pure secretory carcinoma in situ: a case report and literature review". Diagnostic Pathology. 14 (1): 95. doi:10.1186/s13000-019-0872-7. PMC 6706916. PMID 31443715.
Kulka J, Madaras L, Floris G, Lax SF (January 2022). "Papillary lesions of the breast". Virchows Archiv. 480 (1): 65–84. doi:10.1007/s00428-021-03182-7. PMC 8983543. PMID 34734332.
Srinivas V, Harjai MM, Subramanya H, Rajaram T, Rai R (October 2004). "Carcinosarcoma of the Breast With An Unusual Secretory Carcinoma as the Carcinomatous Component". Medical Journal, Armed Forces India. 60 (4): 410–2. doi:10.1016/S0377-1237(04)80027-3. PMC 4923432. PMID 27407689.
Xu J, Weisman P (June 2021). "Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6-NTRK3 fusion in both components". Genes, Chromosomes & Cancer. 60 (6): 447–451. doi:10.1002/gcc.22929. PMID 33342011. S2CID 229341868.
Janik S, Faisal M, Marijić B, Grasl S, Grasl MC, Heiduschka G, Erovic BM (March 2022). "Prognostic factors in mammary analogue secretory carcinomas of the parotid gland: Systematic review and meta-analysis". Head & Neck. 44 (3): 792–804. doi:10.1002/hed.26971. PMID 34964195. S2CID 245539420.
Aref-Eshghi E, Lin F, Li MM, Zhong Y (November 2021). "The oncogenic roles of NTRK fusions and methods of molecular diagnosis". Cancer Genetics. 258–259: 110–119. doi:10.1016/j.cancergen.2021.10.005. PMID 34710798. S2CID 239217797.
Chu YH, Dias-Santagata D, Farahani AA, Boyraz B, Faquin WC, Nosé V, Sadow PM (November 2020). "Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)". Modern Pathology. 33 (11): 2186–2197. doi:10.1038/s41379-020-0574-4. PMC 7584778. PMID 32457407.
Mortensen L, Ordulu Z, Dagogo-Jack I, Bossuyt V, Winters L, Taghian A, Smith BL, Ellisen LW, Kiedrowski LA, Lennerz JK, Bardia A, Spring LM (October 2021). "Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion". The Oncologist. 26 (10): 818–824. doi:10.1002/onco.13880. PMC 8488779. PMID 34176200.

harvard.edu

ui.adsabs.harvard.edu

Gong P, Xia C, Yang Y, Lei W, Yang W, Yu J, Ji Y, Ren L, Ye F (July 2021). "Clinicopathologic profiling and oncologic outcomes of secretory carcinoma of the breast". Scientific Reports. 11 (1): 14738. Bibcode:2021NatSR..1114738G. doi:10.1038/s41598-021-94351-w. PMC 8289843. PMID 34282256.

nih.gov

pubmed.ncbi.nlm.nih.gov

Gong P, Xia C, Yang Y, Lei W, Yang W, Yu J, Ji Y, Ren L, Ye F (July 2021). "Clinicopathologic profiling and oncologic outcomes of secretory carcinoma of the breast". Scientific Reports. 11 (1): 14738. Bibcode:2021NatSR..1114738G. doi:10.1038/s41598-021-94351-w. PMC 8289843. PMID 34282256.
Carretero-Barrio I, Santón A, Caniego Casas T, López Miranda E, Reguero-Callejas ME, Pérez-Mies B, Benito A, Palacios J (February 2022). "Cytological and molecular characterization of secretory breast carcinoma". Diagnostic Cytopathology. 50 (7): E174–E180. doi:10.1002/dc.24945. PMC 9303577. PMID 35156343. S2CID 246813006.
McDivitt RW, Stewart FW (January 1966). "Breast carcinoma in children". JAMA. 195 (5): 388–90. doi:10.1001/jama.1966.03100050096033. PMID 4285563.
Novochadlo Klüppel E, Rodrigues da Costa L, Marquetto Tognolo C, do Nascimento A, Grignet Ribeiro M, Girardi Fachin C (2020). "Secretory breast carcinoma in a male child: Case report and literature review". International Journal of Surgery Case Reports. 73: 310–314. doi:10.1016/j.ijscr.2020.07.040. PMC 7394736. PMID 32736235.
Knaus ME, Grabowksi JE (August 2021). "Pediatric Breast Masses: An Overview of the Subtypes, Workup, Imaging, and Management". Advances in Pediatrics. 68: 195–209. doi:10.1016/j.yapd.2021.05.006. PMID 34243852. S2CID 235786044.
Loo SK, Yates ME, Yang S, Oesterreich S, Lee AV, Wang XS (May 2022). "Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance". Genes, Chromosomes & Cancer. 61 (5): 261–273. doi:10.1002/gcc.23029. PMC 8930468. PMID 35106856.
Tavassoli FA, Norris HJ (May 1980). "Secretory carcinoma of the breast". Cancer. 45 (9): 2404–13. doi:10.1002/1097-0142(19800501)45:9<2404::aid-cncr2820450928>3.0.co;2-8. PMID 6445777. S2CID 9074530.
Hoda RS, Brogi E, Pareja F, Nanjangud G, Murray MP, Weigelt B, Reis-Filho JS, Wen HY (August 2019). "Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential". Histopathology. 75 (2): 213–224. doi:10.1111/his.13879. PMC 6646069. PMID 31012486.
Vasanthi V, Ramadoss R (2021). "Secretory carcinoma of salivary gland - A systematic review of pediatric case reports and case series". Journal of Oral and Maxillofacial Pathology. 25 (2): 327–331. doi:10.4103/0973-029X.325236. PMC 8491356. PMID 34703129.
Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simões M, Tallini G, Mete O (March 2022). "Overview of the 2022 WHO Classification of Thyroid Neoplasms". Endocrine Pathology. 33 (1): 27–63. doi:10.1007/s12022-022-09707-3. PMID 35288841. S2CID 247440666.
Amin SM, Beattie A, Ling X, Jennings LJ, Guitart J (November 2016). "Primary Cutaneous Mammary Analog Secretory Carcinoma With ETV6-NTRK3 Translocation". The American Journal of Dermatopathology. 38 (11): 842–845. doi:10.1097/DAD.0000000000000590. PMID 27763904. S2CID 46372654.
Taniguchi K, Yanai H, Kaji T, Kubo T, Ennishi D, Hirasawa A, Yoshino T (August 2021). "Secretory carcinoma of the skin with lymph node metastases and recurrence in both lungs: A case report". Journal of Cutaneous Pathology. 48 (8): 1069–1074. doi:10.1111/cup.14028. PMID 33882152. S2CID 233352244.
Tang H, Zhong L, Jiang H, Zhang Y, Liang G, Chen G, Xie G (June 2021). "Secretory carcinoma of the breast with multiple distant metastases in the brain and unfavorable prognosis: a case report and literature review". Diagnostic Pathology. 16 (1): 56. doi:10.1186/s13000-021-01115-1. PMC 8223364. PMID 34162406.
Banerjee N, Banerjee D, Choudhary N (2021). "Secretory carcinoma of the breast, commonly exhibits the features of low grade, triple negative breast carcinoma- A Case report with updated review of literature". Autopsy & Case Reports. 11: e2020227. doi:10.4322/acr.2020.227. PMC 8101654. PMID 34277491.
Li L, Wu N, Li F, Li L, Wei L, Liu J (February 2019). "Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma". Cancer Biology & Medicine. 16 (1): 139–146. doi:10.20892/j.issn.2095-3941.2018.0035. PMC 6528460. PMID 31119054.
Yang Y, Wang Z, Pan G, Li S, Wu Y, Liu L (August 2019). "Pure secretory carcinoma in situ: a case report and literature review". Diagnostic Pathology. 14 (1): 95. doi:10.1186/s13000-019-0872-7. PMC 6706916. PMID 31443715.
Kulka J, Madaras L, Floris G, Lax SF (January 2022). "Papillary lesions of the breast". Virchows Archiv. 480 (1): 65–84. doi:10.1007/s00428-021-03182-7. PMC 8983543. PMID 34734332.
Srinivas V, Harjai MM, Subramanya H, Rajaram T, Rai R (October 2004). "Carcinosarcoma of the Breast With An Unusual Secretory Carcinoma as the Carcinomatous Component". Medical Journal, Armed Forces India. 60 (4): 410–2. doi:10.1016/S0377-1237(04)80027-3. PMC 4923432. PMID 27407689.
Xu J, Weisman P (June 2021). "Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6-NTRK3 fusion in both components". Genes, Chromosomes & Cancer. 60 (6): 447–451. doi:10.1002/gcc.22929. PMID 33342011. S2CID 229341868.
Janik S, Faisal M, Marijić B, Grasl S, Grasl MC, Heiduschka G, Erovic BM (March 2022). "Prognostic factors in mammary analogue secretory carcinomas of the parotid gland: Systematic review and meta-analysis". Head & Neck. 44 (3): 792–804. doi:10.1002/hed.26971. PMID 34964195. S2CID 245539420.
Aref-Eshghi E, Lin F, Li MM, Zhong Y (November 2021). "The oncogenic roles of NTRK fusions and methods of molecular diagnosis". Cancer Genetics. 258–259: 110–119. doi:10.1016/j.cancergen.2021.10.005. PMID 34710798. S2CID 239217797.
Chu YH, Dias-Santagata D, Farahani AA, Boyraz B, Faquin WC, Nosé V, Sadow PM (November 2020). "Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)". Modern Pathology. 33 (11): 2186–2197. doi:10.1038/s41379-020-0574-4. PMC 7584778. PMID 32457407.
Mortensen L, Ordulu Z, Dagogo-Jack I, Bossuyt V, Winters L, Taghian A, Smith BL, Ellisen LW, Kiedrowski LA, Lennerz JK, Bardia A, Spring LM (October 2021). "Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion". The Oncologist. 26 (10): 818–824. doi:10.1002/onco.13880. PMC 8488779. PMID 34176200.

ncbi.nlm.nih.gov

Gong P, Xia C, Yang Y, Lei W, Yang W, Yu J, Ji Y, Ren L, Ye F (July 2021). "Clinicopathologic profiling and oncologic outcomes of secretory carcinoma of the breast". Scientific Reports. 11 (1): 14738. Bibcode:2021NatSR..1114738G. doi:10.1038/s41598-021-94351-w. PMC 8289843. PMID 34282256.
Carretero-Barrio I, Santón A, Caniego Casas T, López Miranda E, Reguero-Callejas ME, Pérez-Mies B, Benito A, Palacios J (February 2022). "Cytological and molecular characterization of secretory breast carcinoma". Diagnostic Cytopathology. 50 (7): E174–E180. doi:10.1002/dc.24945. PMC 9303577. PMID 35156343. S2CID 246813006.
Novochadlo Klüppel E, Rodrigues da Costa L, Marquetto Tognolo C, do Nascimento A, Grignet Ribeiro M, Girardi Fachin C (2020). "Secretory breast carcinoma in a male child: Case report and literature review". International Journal of Surgery Case Reports. 73: 310–314. doi:10.1016/j.ijscr.2020.07.040. PMC 7394736. PMID 32736235.
Loo SK, Yates ME, Yang S, Oesterreich S, Lee AV, Wang XS (May 2022). "Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance". Genes, Chromosomes & Cancer. 61 (5): 261–273. doi:10.1002/gcc.23029. PMC 8930468. PMID 35106856.
Hoda RS, Brogi E, Pareja F, Nanjangud G, Murray MP, Weigelt B, Reis-Filho JS, Wen HY (August 2019). "Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential". Histopathology. 75 (2): 213–224. doi:10.1111/his.13879. PMC 6646069. PMID 31012486.
Vasanthi V, Ramadoss R (2021). "Secretory carcinoma of salivary gland - A systematic review of pediatric case reports and case series". Journal of Oral and Maxillofacial Pathology. 25 (2): 327–331. doi:10.4103/0973-029X.325236. PMC 8491356. PMID 34703129.
Tang H, Zhong L, Jiang H, Zhang Y, Liang G, Chen G, Xie G (June 2021). "Secretory carcinoma of the breast with multiple distant metastases in the brain and unfavorable prognosis: a case report and literature review". Diagnostic Pathology. 16 (1): 56. doi:10.1186/s13000-021-01115-1. PMC 8223364. PMID 34162406.
Banerjee N, Banerjee D, Choudhary N (2021). "Secretory carcinoma of the breast, commonly exhibits the features of low grade, triple negative breast carcinoma- A Case report with updated review of literature". Autopsy & Case Reports. 11: e2020227. doi:10.4322/acr.2020.227. PMC 8101654. PMID 34277491.
Li L, Wu N, Li F, Li L, Wei L, Liu J (February 2019). "Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma". Cancer Biology & Medicine. 16 (1): 139–146. doi:10.20892/j.issn.2095-3941.2018.0035. PMC 6528460. PMID 31119054.
Yang Y, Wang Z, Pan G, Li S, Wu Y, Liu L (August 2019). "Pure secretory carcinoma in situ: a case report and literature review". Diagnostic Pathology. 14 (1): 95. doi:10.1186/s13000-019-0872-7. PMC 6706916. PMID 31443715.
Kulka J, Madaras L, Floris G, Lax SF (January 2022). "Papillary lesions of the breast". Virchows Archiv. 480 (1): 65–84. doi:10.1007/s00428-021-03182-7. PMC 8983543. PMID 34734332.
Srinivas V, Harjai MM, Subramanya H, Rajaram T, Rai R (October 2004). "Carcinosarcoma of the Breast With An Unusual Secretory Carcinoma as the Carcinomatous Component". Medical Journal, Armed Forces India. 60 (4): 410–2. doi:10.1016/S0377-1237(04)80027-3. PMC 4923432. PMID 27407689.
Chu YH, Dias-Santagata D, Farahani AA, Boyraz B, Faquin WC, Nosé V, Sadow PM (November 2020). "Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)". Modern Pathology. 33 (11): 2186–2197. doi:10.1038/s41379-020-0574-4. PMC 7584778. PMID 32457407.
Mortensen L, Ordulu Z, Dagogo-Jack I, Bossuyt V, Winters L, Taghian A, Smith BL, Ellisen LW, Kiedrowski LA, Lennerz JK, Bardia A, Spring LM (October 2021). "Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion". The Oncologist. 26 (10): 818–824. doi:10.1002/onco.13880. PMC 8488779. PMID 34176200.

semanticscholar.org

api.semanticscholar.org

Carretero-Barrio I, Santón A, Caniego Casas T, López Miranda E, Reguero-Callejas ME, Pérez-Mies B, Benito A, Palacios J (February 2022). "Cytological and molecular characterization of secretory breast carcinoma". Diagnostic Cytopathology. 50 (7): E174–E180. doi:10.1002/dc.24945. PMC 9303577. PMID 35156343. S2CID 246813006.
Knaus ME, Grabowksi JE (August 2021). "Pediatric Breast Masses: An Overview of the Subtypes, Workup, Imaging, and Management". Advances in Pediatrics. 68: 195–209. doi:10.1016/j.yapd.2021.05.006. PMID 34243852. S2CID 235786044.
Tavassoli FA, Norris HJ (May 1980). "Secretory carcinoma of the breast". Cancer. 45 (9): 2404–13. doi:10.1002/1097-0142(19800501)45:9<2404::aid-cncr2820450928>3.0.co;2-8. PMID 6445777. S2CID 9074530.
Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK, LiVolsi VA, Papotti MG, Sobrinho-Simões M, Tallini G, Mete O (March 2022). "Overview of the 2022 WHO Classification of Thyroid Neoplasms". Endocrine Pathology. 33 (1): 27–63. doi:10.1007/s12022-022-09707-3. PMID 35288841. S2CID 247440666.
Amin SM, Beattie A, Ling X, Jennings LJ, Guitart J (November 2016). "Primary Cutaneous Mammary Analog Secretory Carcinoma With ETV6-NTRK3 Translocation". The American Journal of Dermatopathology. 38 (11): 842–845. doi:10.1097/DAD.0000000000000590. PMID 27763904. S2CID 46372654.
Taniguchi K, Yanai H, Kaji T, Kubo T, Ennishi D, Hirasawa A, Yoshino T (August 2021). "Secretory carcinoma of the skin with lymph node metastases and recurrence in both lungs: A case report". Journal of Cutaneous Pathology. 48 (8): 1069–1074. doi:10.1111/cup.14028. PMID 33882152. S2CID 233352244.
Xu J, Weisman P (June 2021). "Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6-NTRK3 fusion in both components". Genes, Chromosomes & Cancer. 60 (6): 447–451. doi:10.1002/gcc.22929. PMID 33342011. S2CID 229341868.
Janik S, Faisal M, Marijić B, Grasl S, Grasl MC, Heiduschka G, Erovic BM (March 2022). "Prognostic factors in mammary analogue secretory carcinomas of the parotid gland: Systematic review and meta-analysis". Head & Neck. 44 (3): 792–804. doi:10.1002/hed.26971. PMID 34964195. S2CID 245539420.
Aref-Eshghi E, Lin F, Li MM, Zhong Y (November 2021). "The oncogenic roles of NTRK fusions and methods of molecular diagnosis". Cancer Genetics. 258–259: 110–119. doi:10.1016/j.cancergen.2021.10.005. PMID 34710798. S2CID 239217797.